Copyright
©The Author(s) 2015.
World J Gastrointest Endosc. Jul 25, 2015; 7(9): 895-911
Published online Jul 25, 2015. doi: 10.4253/wjge.v7.i9.895
Published online Jul 25, 2015. doi: 10.4253/wjge.v7.i9.895
Ref. | Methodology | Results | Limitations | Conclusions |
Bedirli et al[3] | Study type: prospective, randomised, double-blinded Patients: N = 80; 1–16 yr; ASA I, II Procedure: upper GI endoscopy Drugs: baseline: propofol (1 mg/kg; additional 0.5–1 mg/kg as needed); intervention: fentanyl (2 μg/kg) vs tramadol (2 mg/kg) Intended sedation level: deep sedation Additional interventions: spray of lidocaine 10%; infusion of 10 lactated Ringer’s solution (10 mL/kg per hour); supplemental oxygen 3–4 L/min) Administered by: anesthesiologist Outcome measures: Adverse events: HR (change for 20% from the baseline), BP (change for 20% from the baseline), SpO2 (< 90% for more than 15 s), respiratory rate, agitation score Effectiveness: Ramsey sedation score, duration of endoscopy, Steward recovery score, endoscopist’s rating of ease of procedure, total propofol consumption | Adverse events: self-limited bradycardia and transient desaturation in age group 0–2 yr, more in the fentanyl group Effectiveness: lower sedation scores in tramadol group; no difference of gastroenterologist rating | Only one dosage of drugs instead of titrating them | Propofol with tramadol or propofol provided efficient sedation; significantly less adverse effects in the tramadol group |
Brecelj et al[4] | Study type: randomized, controlled, single-blinded Patients: N = 201; 1–18 yr Procedure: gastroscopy, colonoscopy Drugs: ketamine (0.75 mg/kg with additions of 0.25 mg/kg up max. to 1.5 mg/kg; repeated after 10–15 min at 0.5 mg/kg as needed) Intervention: midazolam (0.1 mg/kg; max 2.5 mg; repeated after 30–60 min at 0.05 mg/kg as needed) vs no premedication Intended sedation level: deep sedation Additional interventions: none Administered by: dedicated nurse under supervision of endoscopist Outcome measures: Adverse events: respiration rate, HR, BP, SaO2 (any drop below 92%), adverse reactions Effectiveness: ease of procedure, total ketamine consumption | Adverse events: mild self-limited laryngospasm in 3%, high rate of desaturations (approx. in 40%), vomiting in 17%, regardless of study group; more emergence reactions in ketamine group during recovery (10 vs 2) Effectiveness: high rate of sedation adequacy | Study was not double-blinded | Ketamine starting dose should be at least 1 mg/kg; more emergence reactions without midazolam premedication; same frequency of other adverse reactions |
Miqdady et al[5] | Study type: retrospective cohort study Patients: N = 301; 1 (more than 10 kg) –18 yr; ASA I, II Procedure: upper, lower or combined GI endoscopy Drugs: atropine (0.01–0.02 mg/kg per minute. 0.1 mg, max. 0.4 mg); midazolam (0.05–0.2 mg/kg); ketamine (0.5–1 mg/kg) Intended sedation level: deep sedation Additional interventions: none Administered by: endoscopist Outcome measures: Adverse events: respiration rate, HR, BP, SaO2 (any drop below 94%), side effects Effectiveness: the adequacy of sedation | Adverse events: desaturation in 12.3%, in 1.2% disruption of examination due to persistent desaturation; in 1.2% respiratory distress after examination Effectiveness: effective and uneventful sedation in 79.4% | Retrospective study | Midazolam and ketamine sedation is safe and effective for diagnostic GI endoscopies in children older than 1 yr weighting more than 10 kg without comorbidities |
Motamed et al[6] | Study type: prospective, randomised, double-blinded Patients: N = 150; 1–18 yr; ASA I, II Procedure: upper GI endoscopy Drugs: main sedative: midazolam (0.1 mg/kg; if needed repeated doses up to 5 mg or 0.3 mg/kg); premedication 45 min before the procedure with oral placebo (normal saline), oral ketamin (5 mg/kg), or oral fentanyl (2 μg/kg) Additional interventions: spray of lidocaine 10%; additional oxygen trough nasal cannula at 2 L/min Administered by: registered nurse supervised by anaesthesiologist Outcome measures: Adverse events: respiration rate, HR (decrease by 30% from baseline), BP (decrease or increase by 20%), SaO2 (any drop below 90%) Effectiveness: total midazolam dose, modified Ramsey sedation score, procedure time, discharge time, ease of iv catheter placement, separation from parents agitation, the adequacy of sedation | Adverse events: in total in 26% of patients (hypoxia in 7.3%, hypotension in 6.7%, dizziness in 20%, nausea in 10%, vomiting in 17.6%); mild, easily managed Effectiveness: the total recovery and procedure duration time was shorter in the ketamine-midazolam group, inadequate sedation in 10.2% in placebo-midazolam and in 8% in fentanyl-midazolam vs in 3.9% in ketamine-midazolam group; the mean administered dose of midazolam was the lowest in ketamine-midazolam group; the iv line placement and separation from parents was easier in ketamine-midazolam group; only 27.4% of patients did not remember the procedure | Sedation with oral ketamine-iv midazolam is better than placebo-midazolam or oral fentanyl-iv midazolam | |
Chiaretti et al[7] | Study type: retrospective (12 yr), multicentric Patients: N = 36516; 1 to > 10 yr; ASA I, II, III Procedure: different painful procedures Drugs: main sedative: propofol 2 mg/kg in children from 1 to 8 yr of age and 1 mg/kg in older children and in children younger than 1 yr; further doses of 0.5–1.0 mg/kg in the case of agitation or complain; premedication: atropine 0.010–0.015 mg/kg, ketamine (0.5 mg/kg) to avoid infusion pain in 2 centres (not in gastroscopy); additional oxygen trough nasal cannula at 6 L/min Intended sedation level: deep sedation Administered by: paediatrician (anaesthesiologist available in case of need) Outcome measures: mean arterial pressure, heart rate and SatO2, incidence, type and timing of adverse events (major and minor) and number of calls to the emergency team Effectiveness: total dosage of the sedative agents, level of sedation (Ramsay scale) | Adverse events: in 6 patients (0.02%) emergency team intervention (prolonged laryngospasm in 3 patients, bleeding in 1, intestinal perforation in 1, and 1 during lumbar puncture); milder adverse events: hypotension in 19 patients (0.05%), ventilation by face mask and additional oxygen in 128 patients (0.4%), laryngospasm in 78 patients (0.2%), bronchospasm in 15 patients (0.04%); minor complications more often in children who underwent gastroscopy; none of the children experienced severe side effects or prolonged hospitalisation. | Retrospective study | Propofol is safe and effective for paediatrician-administered procedural sedation in children; appropriate training for paediatricians is important |
Gül et al[8] | Study type: randomized, controlled, double-blinded Patients: N = 64; 3-14 yr; ASA I Procedure: esophagogastroduodenoscopy Drugs: main sedative: propofol 2 mg/kg; analgesic: group R: remifentanil 0.25 μg/kg, group F: fentanyl 0.5 μg/kg; additional oxygen trough nasal cannula at 4 L/min Intended sedation level: deep sedation Administered by: anesthesiologist Outcome measures: MAP, HR, RR, and SpO2 Effectiveness: ease of gastroscopy, patient’s movements during procedure, additional doses of drugs; level of sedation (Ramsay scale); duration of PACU stay | Adverse events: prolonged apnoea in 14 (43.8%) children in group R and in 11 (33.3%) children in group F; none required endotracheal intubation; Effectiveness intraoperative respiratory rate, time to eye opening, opioid consumption, and duration of recovery were significantly shorter in group R duration of PACU stay were significantly shorter in group R than in group F | Remifentanil (combined with propofol) is an efficient and as safe as fentanyl propofol combination for esophagogastroduodenoscopy in children | |
Long et al[9] | Study type: retrospective analysis of prospectively collected data Patients: N = 4904; 15-90 yr; ASA I-IV Procedure: esophagogastroduodenoscopy Drugs propofol 1-100 mg and/or midazolam 1-3 mg2 mg/kg Administered by: endoscopist Outcome measures: influence of pre-existing disease and ASA score on oxygen desaturation (SpO2) < 90% | Adverse events: hypoxemia in 245 patients (5%); risk factors: high BMI (30 kg/m2), hypertension, diabetes, gastrointestinal disease, heart disease ASA score was not predictive for hypoxemia | Retrospective study | Independent risk factors for hypoxemia were high BMI, hypertension, diabetes, gastrointestinal and heart diseases and combined gastro and colonoscopy |
Agostoni et al[10] | Study type: retrospective analysis of prospectively collected data Patients: N = 17999 (17524 in older than 12 yr, 457 in < 12 yr); 4-74 yr; ASA I-IV Procedure: esophagogastroduodenoscopy and in some cases different procedures (mucosectomy, hemostatic clip, percutaneous endoscopic gastrostomy, …) Drugs: propofol induction (in children 1-2 mg/kg BW) then in continous infusion Intended sedation level: deep sedation Administered by: anesthesiologist Outcome measures: adverse events (hypotension, desaturation, bradycardia, hypertension, arrhythmia, aspiration, respiratory depression, vomiting, cardiac arrest, respiratory arrest, angina, hypoglycemia, and/or allergic reaction) | Adverse events: rare in children (2.6%) and in adults (4.5%), in children were more often only bradycardia (2.1%) and hypotension (0.44%) 3 adult patients died; no death case in children | Retrospective analysis, single centre data | Deep sedation with intravenous propofol for endoscopic procedures is safe in children and adults |
- Citation: Orel R, Brecelj J, Dias JA, Romano C, Barros F, Thomson M, Vandenplas Y. Review on sedation for gastrointestinal tract endoscopy in children by non-anesthesiologists. World J Gastrointest Endosc 2015; 7(9): 895-911
- URL: https://www.wjgnet.com/1948-5190/full/v7/i9/895.htm
- DOI: https://dx.doi.org/10.4253/wjge.v7.i9.895